newsfilter
← Latest News
Business Wire·

AVROBIO to Present at Cowen's 2nd Annual Genetic Medicines Summit

AVROBIO, Inc. (NASDAQ:AVRO), a leading clinical-stage gene therapy company with a shared purpose to free people from a lifetime of genetic disease, today announced Azadeh Golipour, Ph.D., chief technology officer at AVROBIO, will present virtually at Co